Colombia Surrogacy Screening in 2026: Why C-Section History and Pregnancy Ethics Matter

Colombia Surrogacy Screening in 2026: Why C-Section History and Pregnancy Ethics Matter

As Colombia develops into a major destination for international surrogacy, leading fertility programs are paying closer attention to one issue that intended parents often overlook:

the surrogate’s previous pregnancy and delivery history.

Surrogate matching is not simply about finding a woman who is willing to carry a pregnancy.

A medically responsible program must determine whether another pregnancy would expose her—or the baby—to an unreasonable level of risk.

For this reason, previous cesarean deliveries, uterine surgery, pregnancy complications, and the surrogate’s overall obstetric history must be reviewed before embryo transfer.

Does a Previous C-Section Automatically Disqualify a Surrogate?

No.

A prior cesarean section does not automatically mean that a woman cannot become a gestational surrogate.

However, it is an important medical factor.

Fertility specialists should review:

  • The total number of previous cesarean deliveries
  • The reason each cesarean was performed
  • The time since the most recent delivery
  • The condition and thickness of the uterine scar
  • Previous placental complications
  • Any history of hemorrhage
  • Any history of uterine rupture
  • The outcomes of previous pregnancies
  • The surrogate’s current uterine cavity and general health

International professional guidance recommends a comprehensive medical evaluation of gestational carriers, including obstetric history, physical examination, laboratory testing, psychosocial assessment, and uterine cavity evaluation.

The correct question is therefore not:

“Has she ever had a C-section?”

The better question is:

“After a complete medical review, is another pregnancy reasonably safe for this woman?”

Why Repeated C-Sections Require More Caution

Each previous uterine surgery can affect future pregnancy risk.

This does not mean every woman with two prior cesareans is automatically unsuitable. It means her records deserve closer scrutiny and the final decision should be made by a qualified fertility specialist and obstetric team—not by a sales agency.

A responsible clinic should never approve a surrogate based only on age, appearance, or a brief questionnaire.

Her complete pregnancy and delivery records matter.

In Colombia surrogacy, this is especially important because the intended parents may live thousands of miles away and depend on the local clinic to identify risks honestly before transfer.

“No-Scar Uterus” Is a Marketing Phrase, Not a Universal Medical Rule

Some agencies use expressions such as “no-scar uterus” to suggest that only women who have never undergone a cesarean delivery should become surrogates.

That is too simplistic.

A woman with no previous cesarean may still have other medical risks.

A woman with one previous uncomplicated cesarean may, after specialist review, still be considered medically suitable.

The standard should be individualized medical assessment—not a slogan.

What matters is whether the candidate has a history of healthy pregnancy, a suitable uterine cavity, no major unresolved obstetric risk, and a realistic chance of completing another pregnancy safely.

Why Single-Embryo Transfer Matters

One of the most effective ways to protect a gestational surrogate is to reduce avoidable multiple-pregnancy risk.

REDLARA’s published regional data have repeatedly highlighted the relationship between transferring multiple embryos, multiple gestation, prematurity, and perinatal complications. Its Latin American registry has called for fewer embryos to be transferred because twins and higher-order pregnancies carry substantially greater risks than singleton pregnancies.

For modern Colombia surrogacy programs, this supports a clear medical principle:

The goal should not be to create the largest possible pregnancy. The goal should be one healthy baby and one healthy surrogate.

This is why responsible programs increasingly favor single-embryo transfer when medically appropriate.

Intended Parents Cannot Control Every Pregnancy Decision

A surrogacy contract cannot turn a pregnant woman into medical property.

The gestational surrogate must receive full information about the risks, provide informed consent, obtain appropriate legal advice, and retain meaningful autonomy over medical care during pregnancy.

ASRM’s ethics guidance states that gestational-carrier arrangements can be ethically justified when the carrier receives complete information, independent legal advice, healthcare, emotional support, and psychological counseling.

That means intended parents and agencies should not assume they can demand a termination or fetal reduction for non-medical reasons.

Questions involving serious fetal abnormality, maternal danger, multifetal pregnancy, or termination must be discussed before treatment and addressed through medical judgment, informed consent, applicable law, and independent legal advice.

Why Non-Medical Sex Selection Creates Ethical Risk

One particularly troubling scenario is pressure to terminate or reduce a pregnancy because the sex of a fetus does not match an intended parent’s preference.

This is not responsible family building.

A professional surrogacy program should never treat a surrogate pregnancy as a consumer order that can be changed because the outcome does not match a preferred characteristic.

The safest approach is prevention:

  • Discuss embryo-testing limitations before treatment
  • Transfer a medically appropriate number of embryos
  • Explain the possibility of pregnancy complications
  • Establish clear decision-making principles before transfer
  • Ensure the surrogate receives independent advice
  • Avoid contracts that attempt to remove her medical autonomy

Better Screening Can Increase Program Costs

Thorough screening costs money.

A responsible program may need to obtain previous delivery records, arrange specialist reviews, perform uterine imaging, conduct psychological assessments, complete infectious-disease testing, and provide independent legal counseling.

These expenses can make a professionally managed Colombia surrogacy program more costly than a low-price agency offer.

However, it would be misleading to claim that one specific screening requirement alone has fixed the national price of an existing-embryo program at USD $59,000.

Colombia does not have one official national surrogacy price.

Program costs vary according to:

  • Surrogate screening and support
  • Number of transfer attempts
  • IVF laboratory services
  • Pregnancy care
  • Delivery coverage
  • Legal work
  • Birth registration
  • Parentage procedures
  • Insurance and complication coverage
  • International embryo transportation

Intended parents should therefore compare the actual scope of coverage—not just the advertised total.

What Intended Parents Should Ask

Before accepting a surrogate match in Colombia, intended parents should ask:

What were her previous pregnancy outcomes?

How many vaginal and cesarean deliveries has she had?

Were the original obstetric records reviewed?

Has her uterine cavity been evaluated?

Who gave final medical clearance?

Is single-embryo transfer the standard approach?

Does she have independent psychological and legal support?

Who makes medical decisions if complications arise?

What expenses are covered if the pregnancy becomes high-risk?

These questions are more valuable than being told that a candidate has simply “passed screening.”

The Canbaby Surrogacy Perspective

At Canbaby Surrogacy, we believe surrogate screening should protect two goals at the same time:

a reasonable chance of success for the intended parents and a medically responsible pregnancy for the surrogate.

As an embryologist-led team, we do not believe success means completing as many transfers as possible.

Success means selecting an embryo with a reasonable reproductive potential, transferring it through an experienced laboratory, choosing a medically suitable gestational surrogate, and avoiding preventable pregnancy risks.

A candidate’s previous cesarean history should never be ignored.

But it should also never be reduced to an inaccurate marketing slogan.

The decision must be based on records, medical evidence, specialist judgment, informed consent, and respect for the surrogate’s health.

Colombia’s future as an international surrogacy destination will not be secured by the lowest price.

It will be secured by better screening, safer embryo-transfer practices, stronger medical ethics, and transparent care for every person involved.

Keywords: Colombia Surrogacy Screening, Colombia Surrogate Requirements 2026, C-Section and Surrogacy Colombia, Bogotá IVF Clinic, REDLARA Colombia IVF, Single Embryo Transfer Colombia, Ethical Colombia Surrogacy, Gestational Carrier Medical Screening, Colombia Surrogacy Cost, Canbaby Surrogacy.